Scottish Antimicrobial Prescribing Group (SAPG): Development and impact of the Scottish National Antimicrobial Stewardship Programme

International Journal of Antimicrobial Agents

Volumn 38, Issue 1, 2011, Pages 16-26

  Nathwani, Dilip ^a   Sneddon, Jacqueline ^b   Malcolm, William ^c   Wiuff, Camilla ^c   Patton, Andrea ^b   Hurding, Simon ^d   Eastaway, Anne ^c   Seaton, R Andrew ^e   Watson, Emma ^f   Gillies, Elizabeth ^g   Davey, Peter ^h   Bennie, Marion ⁱ  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Scottish Medicines Consortium   (United Kingdom)

^c HEALTH PROTECTION SCOTLAND   (United Kingdom)

^d NHS HIGHLAND   (United Kingdom)

^e NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^f SCOTTISH GOVERNMENT   (United Kingdom)

^g NHS EDUCATION FOR SCOTLAND   (United Kingdom)

^h UNIVERSITY OF DUNDEE   (United Kingdom)

ⁱ National Medicines Utilisation Unit   (United Kingdom)

Author keywords

Antibiotic prescribing quality indicators; Antimicrobial stewardship; Clostridium difficile; Scotland; Unintended consequences

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; CLINICAL INDICATOR; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED PNEUMONIA; DRUG USE; HEALTH EDUCATION; HOSPITAL CARE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LEADERSHIP; ORGANIZATIONAL DEVELOPMENT; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROFESSIONAL STANDARD; PROGRAM DEVELOPMENT; REVIEW; RISK REDUCTION; TOTAL QUALITY MANAGEMENT; UNITED KINGDOM;

EID: 79958071291     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.02.005     Document Type: Short Survey

References (41)

1. D. Monnet, and K. Kristinsson Turning the tide of antimicrobial resistance: Europe shows the way Euro Surveill 13 2008 pii. 19039
2. S. Mölstad, M. Erntell, H. Hanberger, E. Melander, C. Norman, and G. Skoog Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme Lancet Infect Dis 8 2008 125 132
3. Public Health Wales. About the Welsh Antimicrobial Resistance Programme. http://www.wales.nhs.uk/sites3/page.cfm?orgid=457&pid=28418 [accessed 8 December 2010].
4. F. Allerberger, R. Gareis, V. Jindrák, and M.J. Struelens Antibiotic stewardship implementation in the EU: the way forward Expert Rev Anti Infect Ther 7 2009 1175 1183
5. R.C. Owens Jr. Antimicrobial stewardship: concepts and strategies in the 21st century Diagn Microbiol Infect Dis 61 2008 110 128 (Pubitemid 351509755)
6. R.A. Seaton, D. Nathwani, P. Burton, C. McLaughlin, A.R. MacKenzie, and S. Dundas Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT) Int J Antimicrob Agents 29 2007 693 699 (Pubitemid 46710368)
7. T.H. Dellit, R.C. Owens, J.E. McGowan Jr., D.N. Gerding, R.A. Weinstein, and J.P. Burke Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 2007 159 177 (Pubitemid 46084814)
8. D. Nathwani Scottish Medicines Consortium (SMC) Short Life Working Group Scottish Executive Health Department Healthcare Associated Infection Task Force. Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals J Antimicrob Chemother 57 2006 1189 1196
9. P. Davey, E. Brown, L. Fenelon, R. Finch, I. Gould, and A. Holmes Systematic review of antimicrobial drug prescribing in hospitals Emerg Infect Dis 12 2006 211 216
10. S.R. Arnold, and S.E. Straus Interventions to improve antibiotic prescribing practices in ambulatory care Cochrane Database Syst Rev 2005 CD003539
11. A.P. Tonna, D. Stewart, B. West, I. Gould, and D. McCaig Antimicrobial optimisation in secondary care: the pharmacist as part of a multidisciplinary antimicrobial programme - a literature review Int J Antimicrob Agents 31 2008 511 517
12. J. Cooke, K. Alexander, E. Charani, K. Hand, T. Hills, and P. Howard Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals J Antimicrob Chemother 65 2010 2669 2673
13. L.B. Rice The Maxwell Finland Lecture: for the duration - rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile Clin Infect Dis 46 2008 491 496 (Pubitemid 351263484)
14. X. Song, J.G. Bartlett, K. Speck, A. Naegeli, K. Carroll, and T.M. Perl Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population Infect Control Hosp Epidemiol 29 2008 823 828
15. J. Pépin, N. Saheb, M.A. Coulombe, M.E. Alary, M.P. Corriveau, and S. Authier Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec Clin Infect Dis 41 2005 1254 1260 (Pubitemid 41532667)
16. J. Pépin, L. Valiquette, and B. Cossette Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec CMAJ 173 2005 1037 1042
17. F. Barbut, P. Mastrantonio, M. Delmée, J. Brazier, E. Kuijper, and I. Poxton Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates Clin Microbiol Infect 13 2007 1048 1057 (Pubitemid 47553515)
18. A. Carignan, C. Allard, J. Pépin, B. Cossette, V. Nault, and L. Valiquette Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain Clin Infect Dis 46 2008 1838 1843
19. S. Fowler, A. Webber, B.S. Cooper, A. Phimister, K. Price, and Y. Carter Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series J Antimicrob Chemother 59 2007 990 998
20. K. Weiss, A. Boisvert, M. Chagnon, C. Duchesne, S. Habash, and Y. Lepage Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007 Infect Control Hosp Epidemiol 30 2009 156 162
21. M. Power, N. Wigglesworth, E. Donaldson, P. Chadwick, S. Gillibrand, and D. Goldmann Reducing Clostridium difficile infection in acute care by using an improvement collaborative BMJ 341 2010 c3359
22. M.A. Aldeyab, S. Harbarth, N. Vernaz, M.P. Kearney, M.G. Scott, and C. Funston Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients Antimicrob Agents Chemother 53 2009 2082 2088
23. N. Vernaz, K. Hill, S. Leggeat, D. Nathwani, G. Philips, and P. Bonnabry Temporal effects of antibiotic use and Clostridium difficile infections J Antimicrob Chemother 63 2009 1272 1275
24. F. Ansari, M. Erntell, H. Goossens, and P. Davey The European Surveillance of Antimicrobial Consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006 Clin Infect Dis 49 2009 1496 1504
25. H. Grundmann, D.M. Livermore, C.G. Giske, R. Canton, G.M. Rossolini, and J. Campos Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts Euro Surveill 15 2010 pii=19711
26. K.K. Kumarasamy, M.A. Toleman, T.R. Walsh, J. Bagaria, F. Butt, and R. Balakrishnan Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 10 2010 597 602
27. McGuire M, Keel A, Scott B. A revised framework for national surveillance of healthcare associated infection and the introduction of a new Health Efficiency and Access to Treatment (HEAT) target for Clostridium difficile associated disease (CDAD) for NHS Scotland. http://www.sehd.scot.nhs.uk/mels/ CEL2009-11.pdf [accessed 21 April 2010].
28. P. Davey, J. Sneddon, and D. Nathwani Overview of strategies for overcoming the challenge of antimicrobial resistance Expert Rev Clin Pharmacol 3 2010 667 686
29. Scottish Antimicrobial Prescribing Group (SAPG). http://www. scottishmedicines.org.uk/SAPG/Scottish-Antimicrobial-Prescribing-Group-SAPG - [accessed 24 February 2001].
30. Scottish Patient Safety Alliance. http://www.patientsafetyalliance.scot. nhs.uk/ [accessed 24 February 2001].
31. R. Resar, P. Pronovost, C. Haraden, T. Simmonds, T. Rainey, and T. Nolan Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia Jt Comm J Qual Patient Saf 31 2005 243 248
32. S. Coenen, M. Ferech, F.M. Haaijer-Ruskamp, C.C. Butler, R.H. Vander Stichele, and T.J. Verheij European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe Qual Saf Health Care 16 2007 440 445
33. F. Sundram, A. Guyot, I. Carboo, S. Green, M. Lilaonitkul, and A. Scourfield Clostridium difficile ribotypes O27 and 106: clinical outcomes and risk factors J Hosp Infect 72 2009 111 118
34. M.R. Chassin, J.M. Loeb, S.P. Schmaltz, and R.M. Wachter Accountability measures - using measurement to promote quality improvement N Engl J Med 363 2010 683 688
35. L.I. Solberg, G. Mosser, and S. McDonald The three faces of performance measurement: improvement, accountability, and research Jt Comm J Qual Improv 23 1997 135 147
36. R.J. Perla, L. Provost, and R. Lloyd Accountability measures to promote quality improvement N Engl J Med 363 2010 1975 author reply 1975-6
37. Quality Indicator Study Group An approach to the evaluation of quality indicators of the outcome of care in hospitalized patients, with a focus on nosocomial infection indicators Infect Control Hosp Epidemiol 16 1995 308 316
38. M. de Vos, W. Graafmans, M. Kooistra, B. Meijboom, P. Van der Voort, and G. Westert Using quality indicators to improve hospital care: a review of the literature Int J Qual Health Care 21 2009 119 129
39. R.P. Gaynes Preserving the effectiveness of antibiotics JAMA 303 2010 2293 2294
40. J. Carlet, J. Fabry, and L. Degos The 'zero risk' concept for hospital acquired infections: a risky business! Clin Infect Dis 49 2009 747 749
41. J. Brown, F. Doloresco III, and J.M. Mylotte 'Never events: not every hospital-acquired infection is preventable Clin Infect Dis 49 2009 743 746